Biological Data Visualization Global Market Report 2024

The biological data visualization market size has grown rapidly in recent years. It will grow from $0.61 billion in 2023 to $0.7 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth during the historic period can be attributed to several factors, the adoption of high-throughput technologies, the emergence of single-cell analysis techniques, advancements in imaging techniques, an increasing focus on drug discovery and development, and rising investment in life sciences research.

The biological data visualization market size is expected to see rapid growth in the next few years. It will grow to $1.25 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to several factors, the integration of AI and machine learning for data analysis, the expansion of genomics and proteomics research, increasing demand for personalized medicine, the need for real-time visualization tools, and the increasing adoption of cloud-based solutions. Major trends expected during this period include multi-omics integration, enhanced spatial understanding of biological structures, accelerated data interpretation using automated annotation and labeling, data harmonization and standardization, and interactive exploration of complex datasets using virtual reality (VR) and augmented reality (AR).

The increasing demand for personalized medicine is poised to drive growth in the biological data visualization market. Personalized medicine involves tailoring medical treatment and healthcare interventions to individual patients based on their unique characteristics, including genetic makeup, lifestyle, and preferences. This demand stems from advancements in genomics, greater patient empowerment, and a growing acknowledgment of the significance of personalized treatment approaches. Biological data visualization plays a crucial role in personalized medicine by visually representing patient-specific genetic, molecular, and clinical data to guide customized treatment strategies. For instance, in February 2024, the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved 16 new personalized medicines for rare disease patients, marking a significant increase from the 6 approvals in 2022, as reported by the Personalized Medicine Coalition, a UK-based organization advocating for personalized medicine adoption. Hence, the increasing demand for personalized medicine is fueling the expansion of the biological data visualization market.

Leading companies in the biological data visualization market are concentrating on developing advanced solutions, such as AI-powered single-cell analysis systems, to overcome existing tool limitations and gain a competitive edge. AI-powered single-cell analysis systems integrate artificial intelligence (AI) and machine learning (ML) with single-cell sequencing and analysis techniques. These systems enable high-resolution analysis of data from individual cells, providing insights into cellular heterogeneity, gene expression, and cellular interactions within complex biological systems. For example, in May 2023, Deepcell, a US-based biotechnology firm, launched the REM-I Platform, an AI-powered single-cell analysis system revolutionizing biological research with scalable single-cell imaging, high-dimensional analysis, and cell sorting capabilities. The platform offers features such as label-free classification and sorting of cells based on morphological and phenotypic data, along with real-time, high-resolution visualization of cellular heterogeneity, aiming to expedite cell biology discoveries and drive advancements in morpholomics.

In September 2022, Cadence Design Systems Inc., a US-based provider of intelligent system design solutions, acquired OpenEye Scientific Software Inc. to enhance its Intelligent System Design strategy. This acquisition integrates OpenEye's technologies and expertise in computational molecular design, bolstering Cadence's capabilities in biological data visualization and management. OpenEye Scientific Software Inc., based in the US, specializes in providing solutions for biological data visualization and management.

Major companies operating in the biological data visualization market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Sartorius AG, Nikon Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Carl Zeiss Meditec AG, QIAGEN N.V., Bio-Techne Corporation, Leica Microsystems, Promega Corporation, 10x Genomic Inc., Luminex Corporation, Abcam plc, Oxford Nanopore Technologies Ltd., Cell Signaling Technology Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Fluidigm Corporation.

North America was the largest region in the biological data visualization market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological data visualization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biological data visualization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biological data visualization involves creating graphical representations of complex biological data to aid in understanding, interpreting, and communicating biological phenomena and relationships. This interdisciplinary field merges biology, computer science, and graphic design principles to develop visual tools that assist researchers, clinicians, and educators in analyzing and comprehending large datasets generated from various biological studies.

The primary techniques of biological data visualization include microscopy, magnetic resonance imaging, sequencing, X-ray crystallography, and others. Microscopy utilizes microscopes to visualize objects too small to be seen with the naked eye. It encompasses platforms such as Windows, Mac operating systems, Linux, and others, applied in cell and organism imaging, structural biology and molecular modeling, genomic analysis, alignments, phylogeny, evolution, and systems biology. These techniques find application in academic research, pharmaceutical and biological centers, hospitals and clinics, and other domains.

The biological data visualization market research report is one of a series of new reports that provides biological data visualization market statistics, including the biological data visualization industry global market size, regional shares, competitors with biological data visualization market share, detailed biological data visualization market segments, market trends, and opportunities, and any further data you may need to thrive in the biological data visualization industry. These biological data visualization market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biological data visualization market consists of revenues earned by entities by providing services such as genetic data visualization, transcriptomic data visualization, metabolomic data visualization, evolutionary data visualization, and structural biology visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The biological data visualization market also includes sales of genome browsers, protein structure visualization software and heatmap generators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the developers or creators of these visualization tools, whether to other entities (including research institutions, biotechnology companies, healthcare providers, and educational organizations) or directly to end users. The value of goods in this market includes related services provided by the creators of these tools.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.